Stay updated with breaking news from Ravindrak gupta. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
COVID-19 Collection thelancet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thelancet.com Daily Mail and Mail on Sunday newspapers.
India will soon have another wave so get one dose to as many people as you can: Top virologist indiatimes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from indiatimes.com Daily Mail and Mail on Sunday newspapers.
The Delta variant may be escaping immunity from Covid-19 vaccines qz.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from qz.com Daily Mail and Mail on Sunday newspapers.
World Health Organization declares B.1.617, first identified in India, the fourth variant of concern At their Monday COVID-19 press brief, the World Health Organization (WHO) declared the highly contagious variant first identified in India, classified as B.1.617, as a variant of concern, meaning that it is now considered a global health threat. Dr. Maria Van Kerkhove, the technical lead for the COVID-19 pandemic, explained, “In our consultation with our virus evolution working group, our epidemiology teams, and our lab teams internally, there is some available information to suggest increased transmissibility of B.1.617.” She added that this variant could also reduce neutralization from antibodies, implying it has the ability to evade immunity to some degree, one of the key reasons it was classified as a variant of concern. The designation is used for those mutations that have been demonstrated to be more contagious, deadly or resistant to the COVID-19 vaccines current ....
The Indian double mutant variant of coronavirus B.1.617 that has been termed as a variant of concern by the World Health Organization is moderately resistant to antibodies and is highly transmissible but has low severity among those who are vaccinated, a molecular study has said. The study published by Indian SARS-CoV-2 Genomic Consortia along with the scientists of the Cambridge University in the UK in the bioRxiv, an open access preprint server, “Extensive vaccination will likely protect against moderate to severe disease and will reduce the transmission of B.1.617 given the in vitro neutralisation data we and others have presented.” ....